Vidaza Side Effects
Post Side Effect
Ask Community
Compare Side Effects
Post Your Vidaza Experience:
Recent Vidaza Side Effect Reports
Vidaza Side Effects Report #5207122-6
Consumer or non-health professional from UNITED STATES reported Vidaza side effect on Dec 27, 2006. Female patient, 86 years of age, weighting 126.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: chest pain
, gastrooesophageal reflux disease. Vidaza dosage: unknown. During the same period patient was treated with VERAPAMIL, PREDNISONE. Patient was hospitalized.
Vidaza Side Effects Report #5213880-7
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 05, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial fibrillation, culture urine positive, enterococcal infection, neutropenic sepsis, no therapeutic response, pericardial effusion, pericarditis, sinus tachycardia, staphylococcal infection . Vidaza dosage: 132.75 MG (75 MG/M2, DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL. Patient was hospitalized. Patient died on 01/08/2007.
Consumer or non-health professional from UNITED STATES reported Vidaza side effect on Dec 27, 2006. Female patient, 86 years of age, weighting 126.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: chest pain
, gastrooesophageal reflux disease. Vidaza dosage: unknown. During the same period patient was treated with VERAPAMIL, PREDNISONE. Patient was hospitalized. 
Vidaza Side Effects Report #5213880-7
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 05, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial fibrillation
, culture urine positive, enterococcal infection, neutropenic sepsis, no therapeutic response, pericardial effusion, pericarditis, sinus tachycardia, staphylococcal infection . Vidaza dosage: 132.75 MG (75 MG/M2, DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL. Patient was hospitalized. Patient died on 01/08/2007. View More
View All Vidaza FDA Adverse Reports
Vidaza Side Effects
Abdominal pain Acute pulmonary oedema Anaemia Asthenia Atrial fibrillation Blood creatinine increased Cerebrovascular accident Colitis ischaemic Condition aggravated Confusional state Diarrhoea Disease progression Dyspnoea Febrile neutropenia Gastrointestinal haemorrhage Haemoglobin decreased Hypotension Nausea Neutropenia Neutrophil count decreased Pancytopenia Platelet count decreased Pneumonia Pulmonary embolism Pyrexia Renal failure Renal failure acute Respiratory failure Sepsis Thrombocytopenia Vomiting White blood cell count decreased
Acute pulmonary oedema Anaemia Asthenia Atrial fibrillation Blood creatinine increased Cerebrovascular accident Colitis ischaemic Condition aggravated Confusional state Diarrhoea Disease progression Dyspnoea Febrile neutropenia Gastrointestinal haemorrhage Haemoglobin decreased Hypotension Nausea Neutropenia Neutrophil count decreased Pancytopenia Platelet count decreased Pneumonia Pulmonary embolism Pyrexia Renal failure Renal failure acute Respiratory failure Sepsis Thrombocytopenia Vomiting White blood cell count decreased
Vidaza Questions
Ask Community about Vidaza:
Comments to date: 1. Page 1 of 1.
John P. Location unknown | 8:33pm on Tuesday, September 23rd, 2008 |
My 73 yo mother was diagnosed with myelodysplasia three months ago. After failing to respond to the ... read more » | |
Ask Community about Vidaza:
Questions to date: 2. Page 1 of 1.
Anonymous Serbia | 11:25am on Saturday, January 23rd, 2010 |
Rola YOusef Shmesani | 6:08am on Sunday, November 22nd, 2009 |
Vidaza Adverse Effect Reports (FDA)
Consumer or non-health professional from PHILIPPINES reported Vidaza side effect on Jan 23, 2007. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: arrhythmia. Vidaza dosage: unknown. During the same period patient was treated with NASEA, DEPAKOTE. Patient died on 01/18/2007.
Vidaza Side Effects Report #5228738-7
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 19, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial fibrillation, cardiopulmonary failure, culture urine positive, enterococcal infection, hypotension, neutropenic sepsis, no therapeutic response, pericarditis, sinus tachycardia. Vidaza dosage: 132.75 MG (75 MG/M2,DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 01/08/2007.
Vidaza Side Effects Report #5229612-2
Physician from UNITED STATES reported Vidaza side effect on Jan 18, 2007. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: coma, dialysis, haemoglobin decreased, haemorrhage, hypotension, leukopenia, pneumonia . Vidaza dosage: 75 MG/M2 (130 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with COUMADIN, LIPITOR, DIGITEX, ATACAND, ARANESP. Patient was hospitalized. Patient died on 02/16/2006.
Vidaza Side Effects Report #5237948-4
Vidaza side effect was reported by a Physician from PHILIPPINES on Feb 01, 2007. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, arrhythmia, asthenia, disease progression, platelet count decreased. Vidaza dosage: 50 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with NASEA, DEPAKOTE. Patient died on 01/18/2007.
Vidaza Side Effects Report #5241458-8
Physician from UNITED STATES reported Vidaza side effect on Jan 26, 2007. Female patient, 47 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: fungal infection, lung neoplasm, pulmonary embolism . Vidaza dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS.
Vidaza Side Effects Report #5286019-X
Vidaza side effect was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient, 79 years of age, weighting 181.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atelectasis, hypotension, hypoxia, pleural effusion, productive cough, renal failure, sepsis, sputum discoloured, sputum purulent. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with METFORMIN, ASPIRIN, DOXYCYCLINE, GUAIFENESIN, POTASSIUM. Patient was hospitalized. Patient died on 03/17/2007.
Vidaza Side Effects Report #5293978-8
Physician from UNITED STATES reported Vidaza side effect on Mar 23, 2007. Female patient, 47 years of age, weighting 135.4 lb, was diagnosed with myelodysplastic syndrome, decreased appetite and was treated with Vidaza. After drug was administered, patient experienced the following side effects: decreased appetite, fungal infection, hepatic infection, lung neoplasm, pulmonary embolism . Vidaza dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with MEGACE, ATIVAN, VFEND, CASPOFUNGIN.
Vidaza Side Effects Report #5343436-7
Vidaza side effect was reported by a Physician from UNITED KINGDOM on May 17, 2007. Male patient, 55 years of age, weighting 188.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood culture positive, blood pressure systolic decreased, condition aggravated, neutropenic sepsis, pseudomonas infection, refusal of treatment by patient, sputum culture positive, white blood cell count decreased. Vidaza dosage: 75 MG/M2 (150 MG ONCE DAILY X FIVE DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE, ATRA, VALACYCLOVIR, METRONIDAZOLE, ADCORTYL IN ORAL BASE, AMILORIDE. Patient was hospitalized. Patient died on 05/09/2007.
Vidaza Side Effects Report #5354898-3
Physician from UNITED STATES reported Vidaza side effect on June 04, 2007. Male patient, 79 years of age, weighting 199.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood potassium decreased, crepitations, decreased appetite, discomfort, dyspnoea exertional, fatigue. Vidaza dosage: 50 MG/M2 (DAYS 1 THROUGH 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with LASIX, COLACE, SENOKOT, NEURONTIN, PENICILLIN. Patient died on 04/26/2007.
Vidaza Side Effects Report #5367782-6
Vidaza side effect was reported by a Physician from UNITED KINGDOM on June 04, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, haemolysis, nausea, polychromasia, red blood cell spherocytes present. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR.
Vidaza Side Effects Report #5049253-X
Pharmacist from UNITED STATES reported Vidaza side effect on June 26, 2006. Male patient was treated with Vidaza. After drug was administered, patient experienced the following side effects: splenic rupture, splenomegaly. Vidaza dosage: unknown.
Vidaza Side Effects Report #5060546-2
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cerebrovascular accident, haemorrhage, pneumonia, sepsis . Vidaza dosage: unknown. During the same period patient was treated with LIPITOR, ATIVAN. Patient was hospitalized. Patient died on 02/16/2006.
Vidaza Side Effects Report #5071698-2
Physician from UNITED STATES reported Vidaza side effect on July 27, 2006. Male patient, 58 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: colitis, ileus, intestinal obstruction, pancreatitis. Vidaza dosage: 75 MG/M2 (140 MG) SUBCUTANEOUS. During the same period patient was treated with ACETAMINOPHEN, PROCHLORPERAZINE MALEATE, IPRATROPIUM. Patient was hospitalized.
Vidaza Side Effects Report #5077823-1
Vidaza side effect was reported by a Physician from UNITED STATES on July 24, 2006. Female patient, 61 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: gastric perforation, septic shock. Vidaza dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with METOPROLOL. Patient was hospitalized. Patient died on 07/11/2006.
Vidaza Side Effects Report #5084852-0
Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF reported Vidaza side effect on Aug 03, 2006. Female patient, 74 years of age, weighting 101.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, epistaxis, febrile neutropenia, hyponatraemia, meningitis bacterial, pancytopenia, pneumonia. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with FOSAMAX. Patient was hospitalized. Patient died on 05/14/2006.
Vidaza Side Effects Report #5097684-4
Vidaza side effect was reported by a Physician from THAILAND on Aug 24, 2006. Male patient, 33 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: infection, nausea , neutropenia. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LPRC, ONDANSETRON. Patient was hospitalized. Patient died on 07/01/2006.
Vidaza Side Effects Report #5120147-4
Physician from THAILAND reported Vidaza side effect on Sept 14, 2006. Male patient, 33 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: diarrhoea, haematocrit decreased, lobar pneumonia, lymphocyte percentage increased, nausea, neutropenia, platelet count decreased, septic shock. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LPRC, ONDANSETRON. Patient was hospitalized. Patient died on 07/01/2006.
Vidaza Side Effects Report #5128618-1
Vidaza side effect was reported by a Physician from UNITED STATES on Sept 26, 2006. Male patient, 51 years of age, weighting 244.9 lb, was diagnosed with metastatic malignant melanoma and was treated with Vidaza. After drug was administered, patient experienced the following side effects: arthropod sting, iritis, local swelling. Vidaza dosage: 75 MG/M2 (DAILY X 3 DAYS EVERY 2 WEEKS), SUBCUTANEOUS. During the same period patient was treated with INTERFERON, AMBIEN CR, FERROUS SULPHATE, PERCOCET, SYNTHROID.
Vidaza Side Effects Report #5144297-1
Consumer or non-health professional from UNITED STATES reported Vidaza side effect on Oct 18, 2006. Female patient, 71 years of age, weighting 150.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain upper, caecitis, vomiting. Vidaza dosage: unknown. Patient was hospitalized.
Vidaza Side Effects Report #5145543-0
Vidaza side effect was reported by a Physician from UNITED STATES on Oct 17, 2006. Female patient, 79 years of age, weighting 183.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, dilatation atrial, epistaxis, thrombocytopenia, ventricular extrasystoles, ventricular hypertrophy. Vidaza dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, SPIRIVA, ADVAIR DISKUS, FLONASE, ALLEGRA, ZOLOFT, FOLATE, METAMUCIL. Patient was hospitalized.
Vidaza Side Effects Report #5146393-1
Physician from UNITED STATES reported Vidaza side effect on Oct 19, 2006. Male patient, 75 years of age, weighting 182.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: amyotrophic lateral sclerosis, bedridden, blood product transfusion dependent, gait disturbance, nerve injury, polyneuropathy. Vidaza dosage: unknown. During the same period patient was treated with SIMVASTATIN.
Vidaza Side Effects Report #5154593-X
Vidaza side effect was reported by a Physician from ITALY on Oct 26, 2006. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cerebral ischaemia, coma hepatic, hepatic failure, hepatic necrosis, pneumonia. Vidaza dosage: 60 MG/M2 (100 MG, DAILY X 8 DAYS, WITHOUT WEEKEND DOSING), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, TRETINOIN, DANAZOLE. Patient died.
Vidaza Side Effects Report #5166006-2
Health Professional from UNITED STATES reported Vidaza side effect on Nov 16, 2006. Female patient, 47 years of age, weighting 115.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pancreatitis. Vidaza dosage: 56 MG/M2 (88 MG, DAILY), SUBCUTANEOUS. During the same period patient was treated with ZOLOFT, QUINAPRIL, PRAVASTATIN, NISOLDIPINE, LORATADINE. Patient was hospitalized.
Vidaza Side Effects Report #5166385-6
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2006. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: haemorrhage, pneumonia, renal failure, sepsis . Vidaza dosage: unknown. Patient was hospitalized. Patient died on 02/01/2006.
Vidaza Side Effects Report #5170131-X
Physician from UNITED STATES reported Vidaza side effect on Nov 16, 2006. Female patient, 47 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atelectasis, cardiac arrest, carotid artery aneurysm, carotid artery atheroma, constipation , electrocardiogram qt corrected interval prolonged, febrile neutropenia, hypokalaemia, hypomagnesaemia. Vidaza dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with AMBISOME, NORFLOXACIN, ZOFRAN, REGLAN, BENADRYL, PROTONIX, TYLENOL. Patient was hospitalized.
Vidaza Side Effects Report #5178223-6
Vidaza side effect was reported by a Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on Nov 24, 2006. Female patient, 68 years of age, weighting 72.75 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: ascites, bone marrow failure, nausea, peritonitis, pneumonia . Vidaza dosage: 75 MG/M2 (DAILY X 7. Patient was hospitalized. Patient died on 11/18/2006.
Vidaza Side Effects Report #5178225-X
Physician from PHILIPPINES reported Vidaza side effect on Nov 23, 2006. Male patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: disease progression. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. Patient died.
Vidaza Side Effects Report #5187668-X
Vidaza side effect was reported by a Physician from UNITED STATES on Nov 28, 2006. Male patient, 75 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bacterial infection, bronchial obstruction, pancytopenia, pneumonia fungal, sputum culture positive. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with FORTAZ, FLEXERIL, AVODART, LOTEMAX, PROTONIX, ZOCOR, BENADRYL, TYLENOL. Patient was hospitalized. Patient died on 12/05/2006.
Vidaza Side Effects Report #5189382-3
Health Professional from FRANCE reported Vidaza side effect on Dec 01, 2006. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bone marrow failure, bone marrow transplant, bronchopulmonary aspergillosis, condition aggravated, febrile bone marrow aplasia, pancytopenia. Vidaza dosage: 75 MG/M2 (DAILY X 6 DAYS), SUBCUTANEOUS. During the same period patient was treated with DANATROL, ARANESP. Patient was hospitalized.
Vidaza Side Effects Report #5191605-1
Vidaza side effect was reported by a Physician from ITALY on Dec 04, 2006. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cerebral ischaemia, coagulopathy, coma hepatic, condition aggravated, hepatic failure, hepatic necrosis, hepatotoxicity, international normalised ratio increased, neutrophil count decreased. Vidaza dosage: 60 MG/M2 (100 MG, DAILY X 8 DAYS, WITHOUT WEEKEND DOSING), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, DANAZOLE, TRETINOIN. Patient died on 10/24/2006.
Vidaza Side Effects Report #5193880-6
Physician from UNITED STATES reported Vidaza side effect on Dec 19, 2006. Male patient, 74 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: hypotension, hypoxia, interstitial lung disease, supraventricular tachycardia. Vidaza dosage: (85 MG, DAILY X 10 DAYS), SUBCUTANEOUS. During the same period patient was treated with TOPROL, FOLTX, ZOLOFT, CARDURA, ZYRTEC, ARANESP. Patient was hospitalized. Patient died on 10/23/2006.
Vidaza Side Effects Report #5195824-X
Vidaza side effect was reported by a Physician from UNITED STATES on Dec 14, 2006. Female patient, 69 years of age, weighting 158.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, bacteria stool identified, bacterial infection, blood pressure decreased, catheter sepsis, condition aggravated, heart rate decreased, heart rate increased, nausea . Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with ZOLOFT, XANAX, ASCORBIC ACID, IRON, CYANOCOBALAMIN, SPIRIVA, ALBUTEROL. Patient was hospitalized. Patient died on 12/12/2006.
Vidaza Side Effects Report #5380511-5
Physician from UNITED KINGDOM reported Vidaza side effect on June 21, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, nausea, polychromasia, red blood cell spherocytes present. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS),INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR.
Vidaza Side Effects Report #5385214-9
Vidaza side effect was reported by a Physician from UNITED KINGDOM on June 22, 2007. Male patient, 68 years of age, weighting 154.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abscess intestinal. Vidaza dosage: (75 MG/M2, SUBCUTANEOUS. During the same period patient was treated with CIPROFLOXACIN, NYSTATIN, ACYCLOVIR. Patient was hospitalized.
Vidaza Side Effects Report #5397276-3
Physician from GERMANY reported Vidaza side effect on July 09, 2007. Male patient, 55 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis of nausea and vomiting and was treated with Vidaza. After drug was administered, patient experienced the following side effects: aggression. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with ONDANSETRON. Patient was hospitalized.
Vidaza Side Effects Report #5398952-9
Vidaza side effect was reported by a Pharmacist from UNITED STATES on July 24, 2007. Female patient, 81 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pancytopenia. Vidaza dosage: unknown. During the same period patient was treated with TYLENOL, HEPARIN, AZTREONAM, CIPROFLOXACIN, ALBUTEROL, IPRATROPIUM BROMIDE, BACTRIM, VANCOMYCIN. Patient was hospitalized. Patient died on 04/04/2006.
Vidaza Side Effects Report #5402040-2
Physician from FRANCE reported Vidaza side effect on July 12, 2007. Male patient, 55 years of age, weighting 220.5 lb, was diagnosed with myelodysplastic syndrome, thrombosis prophylaxis, pyrexia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bacterial infection, catheter related infection, culture urine positive, escherichia infection, international normalised ratio increased, pneumonia klebsiella, sepsis . Vidaza dosage: 120 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with PREVISCAN, AMOXICILLIN, ATENOLOL. Patient was hospitalized.
Vidaza Side Effects Report #5413136-3
Vidaza side effect was reported by a Physician from UNITED STATES on July 26, 2007. Female patient, 78 years of age, weighting 140.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, thrombocytopenia, urinary tract infection. Vidaza dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, ATENOLOL. Patient was hospitalized.
Vidaza Side Effects Report #5422042-X
Physician from UNITED STATES reported Vidaza side effect on Aug 03, 2007. Female patient, 80 years of age, weighting 145.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, carotid arteriosclerosis, haemoglobin decreased, heart rate irregular, hypotension, iron overload, local swelling, loss of consciousness, pyrexia. Vidaza dosage: 75 MG/M2, INTRAVENOUS. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ENALAPRIL, METOPROLOL TARTRATE, ASPIRIN, DEFERASIROX. Patient was hospitalized.
Vidaza Side Effects Report #5422150-3
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Aug 03, 2007. Male patient, 55 years of age, weighting 149.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial flutter, chest x-ray abnormal, diarrhoea, disease recurrence, hypertension, hypotension, pyrexia, tachycardia. Vidaza dosage: 135 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE, CIPROFLOXACIN, ACYCLOVIR, ALLOPURINOL, PENICILLIN V, LANSOPRAZOLE. Patient was hospitalized.
Vidaza Side Effects Report #5443288-0
Physician from GERMANY reported Vidaza side effect on Aug 16, 2007. Male patient, 59 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, aplasia, atrial fibrillation, catheter site haemorrhage, convulsion, febrile neutropenia, haemoptysis, left ventricular failure. Vidaza dosage: (100 MG/M2), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, NEUPOGEN. Patient was hospitalized. Patient died on 07/15/2007.
Vidaza Side Effects Report #5449798-4
Vidaza side effect was reported by a Physician from ITALY on Aug 29, 2007. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, aspergillosis, blood pressure increased, cytomegalovirus infection, epstein-barr virus infection, heart rate increased, pneumocystis jiroveci pneumonia, urinary retention. Vidaza dosage: (140 MG, DAILY X 7). During the same period patient was treated with VALPROIC ACID. Patient was hospitalized. Patient died on 08/24/2007.
Vidaza Side Effects Report #5455009-6
Physician from FRANCE reported Vidaza side effect on Aug 28, 2007. Female patient, 76 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: encephalopathy. Vidaza dosage: 119.3 MG (119.3 MG, DAILY X 7 DAYS), INTRAVENOUS. During the same period patient was treated with VALPROIC ACID, PROPRANOLOL, LEVOTHYROXINE, DESLORATADINE, GINKGO BILOBA. Patient was hospitalized and became disabled.
Vidaza Side Effects Report #5467580-9
Vidaza side effect was reported by a Physician from UNITED STATES on Sept 07, 2007. Male patient, 43 years of age, weighting 242.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain, acute febrile neutrophilic dermatosis, post procedural haematoma, renal failure, respiratory failure, sepsis , vocal cord disorder. Vidaza dosage: (75 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with VORINOSTAT. Patient was hospitalized.
Vidaza Side Effects Report #5472682-7
Physician from ITALY reported Vidaza side effect on Sept 11, 2007. Female patient, 61 years of age, weighting 143.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood culture positive, candidiasis, depressed level of consciousness, neutropenia, pneumonia fungal, septic shock. Vidaza dosage: (125 MG, DAILY X DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, EUTIROX, VALPRESSION. Patient died on 09/02/2007.
Vidaza Side Effects Report #5482167-X
Vidaza side effect was reported by a Physician from FRANCE on Sept 21, 2007. Female patient, 76 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acinetobacter bacteraemia, encephalopathy, vessel puncture site haematoma. Vidaza dosage: 119 MG, DAILY X 7 DAYS, INTRAVENOUS. During the same period patient was treated with VALPROIC ACID, PROPRANOLOL, LEVOTHYROXINE, DESLORATADINE, GINKGO BILOBA, TRETINOIN, ONDANSETRON, DOMPERIDONE. Patient was hospitalized and became disabled.
Vidaza Side Effects Report #5485942-0
Physician from FRANCE reported Vidaza side effect on Oct 08, 2007. Female patient, 76 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acinetobacter bacteraemia, encephalopathy, malignant neoplasm progression, vessel puncture site haematoma. Vidaza dosage: (119 MG, DAILY X 7 DAYS), INTRAVENOUS. During the same period patient was treated with VALPROIC ACID, PROPRANOLOL, LEVOTHYROXINE, DESLORATADINE, GINKGO BILOBA, TRETINOIN, ONDANSETRON, DOMPERIDONE. Patient was hospitalized and became disabled.
Vidaza Side Effects Report #5486003-7
Vidaza side effect was reported by a Physician from ITALY on Sept 28, 2007. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, aspergillosis, blood pressure increased, cytomegalovirus infection, epstein-barr virus infection, haemoglobin decreased, platelet count decreased, pneumocystis jiroveci pneumonia, urinary retention. Vidaza dosage: (140 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, BACTRIM, PREDNISONE, RABEPRAZOLE, FOSFAMICINA, TROMETAMOLO, CARVEDILOLO. Patient was hospitalized. Patient died on 08/24/2007.
Go to the top of the page
Showing 1-50 of 226 Next >
Vidaza Side Effects Report #5225220-8Consumer or non-health professional from PHILIPPINES reported Vidaza side effect on Jan 23, 2007. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: arrhythmia
. Vidaza dosage: unknown. During the same period patient was treated with NASEA, DEPAKOTE. Patient died on 01/18/2007.Vidaza Side Effects Report #5228738-7
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 19, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiopulmonary failure, culture urine positive, enterococcal infection, hypotension, neutropenic sepsis, no therapeutic response, pericarditis, sinus tachycardia. Vidaza dosage: 132.75 MG (75 MG/M2,DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 01/08/2007.Vidaza Side Effects Report #5229612-2
Physician from UNITED STATES reported Vidaza side effect on Jan 18, 2007. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: coma, dialysis
, haemoglobin decreased, haemorrhage, hypotension, leukopenia, pneumonia . Vidaza dosage: 75 MG/M2 (130 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with COUMADIN, LIPITOR, DIGITEX, ATACAND, ARANESP. Patient was hospitalized. Patient died on 02/16/2006.Vidaza Side Effects Report #5237948-4
Vidaza side effect was reported by a Physician from PHILIPPINES on Feb 01, 2007. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, arrhythmia
, asthenia, disease progression, platelet count decreased. Vidaza dosage: 50 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with NASEA, DEPAKOTE. Patient died on 01/18/2007.Vidaza Side Effects Report #5241458-8
Physician from UNITED STATES reported Vidaza side effect on Jan 26, 2007. Female patient, 47 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: fungal infection
, lung neoplasm, pulmonary embolism . Vidaza dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. Vidaza Side Effects Report #5286019-X
Vidaza side effect was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient, 79 years of age, weighting 181.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atelectasis, hypotension, hypoxia, pleural effusion, productive cough, renal failure, sepsis
, sputum discoloured, sputum purulent. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with METFORMIN, ASPIRIN, DOXYCYCLINE, GUAIFENESIN, POTASSIUM. Patient was hospitalized. Patient died on 03/17/2007.Vidaza Side Effects Report #5293978-8
Physician from UNITED STATES reported Vidaza side effect on Mar 23, 2007. Female patient, 47 years of age, weighting 135.4 lb, was diagnosed with myelodysplastic syndrome, decreased appetite and was treated with Vidaza. After drug was administered, patient experienced the following side effects: decreased appetite, fungal infection
, hepatic infection, lung neoplasm, pulmonary embolism . Vidaza dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with MEGACE, ATIVAN, VFEND, CASPOFUNGIN. Vidaza Side Effects Report #5343436-7
Vidaza side effect was reported by a Physician from UNITED KINGDOM on May 17, 2007. Male patient, 55 years of age, weighting 188.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood culture positive, blood pressure systolic decreased, condition aggravated, neutropenic sepsis, pseudomonas infection, refusal of treatment by patient, sputum culture positive, white blood cell count decreased. Vidaza dosage: 75 MG/M2 (150 MG ONCE DAILY X FIVE DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE, ATRA, VALACYCLOVIR, METRONIDAZOLE, ADCORTYL IN ORAL BASE, AMILORIDE. Patient was hospitalized. Patient died on 05/09/2007.
Vidaza Side Effects Report #5354898-3
Physician from UNITED STATES reported Vidaza side effect on June 04, 2007. Male patient, 79 years of age, weighting 199.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood potassium decreased, crepitations, decreased appetite, discomfort, dyspnoea exertional, fatigue. Vidaza dosage: 50 MG/M2 (DAYS 1 THROUGH 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with LASIX, COLACE, SENOKOT, NEURONTIN, PENICILLIN. Patient died on 04/26/2007.
Vidaza Side Effects Report #5367782-6
Vidaza side effect was reported by a Physician from UNITED KINGDOM on June 04, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, haemolysis, nausea
, polychromasia, red blood cell spherocytes present. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR. Vidaza Side Effects Report #5049253-X
Pharmacist from UNITED STATES reported Vidaza side effect on June 26, 2006. Male patient was treated with Vidaza. After drug was administered, patient experienced the following side effects: splenic rupture, splenomegaly. Vidaza dosage: unknown.
Vidaza Side Effects Report #5060546-2
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cerebrovascular accident, haemorrhage, pneumonia
, sepsis . Vidaza dosage: unknown. During the same period patient was treated with LIPITOR, ATIVAN. Patient was hospitalized. Patient died on 02/16/2006.Vidaza Side Effects Report #5071698-2
Physician from UNITED STATES reported Vidaza side effect on July 27, 2006. Male patient, 58 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: colitis, ileus, intestinal obstruction, pancreatitis. Vidaza dosage: 75 MG/M2 (140 MG) SUBCUTANEOUS. During the same period patient was treated with ACETAMINOPHEN, PROCHLORPERAZINE MALEATE, IPRATROPIUM. Patient was hospitalized.
Vidaza Side Effects Report #5077823-1
Vidaza side effect was reported by a Physician from UNITED STATES on July 24, 2006. Female patient, 61 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: gastric perforation, septic shock. Vidaza dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with METOPROLOL. Patient was hospitalized. Patient died on 07/11/2006.
Vidaza Side Effects Report #5084852-0
Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF reported Vidaza side effect on Aug 03, 2006. Female patient, 74 years of age, weighting 101.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, epistaxis, febrile neutropenia, hyponatraemia, meningitis bacterial, pancytopenia, pneumonia
. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with FOSAMAX. Patient was hospitalized. Patient died on 05/14/2006.Vidaza Side Effects Report #5097684-4
Vidaza side effect was reported by a Physician from THAILAND on Aug 24, 2006. Male patient, 33 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: infection
, nausea , neutropenia. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LPRC, ONDANSETRON. Patient was hospitalized. Patient died on 07/01/2006.Vidaza Side Effects Report #5120147-4
Physician from THAILAND reported Vidaza side effect on Sept 14, 2006. Male patient, 33 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: diarrhoea, haematocrit decreased, lobar pneumonia, lymphocyte percentage increased, nausea
, neutropenia, platelet count decreased, septic shock. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LPRC, ONDANSETRON. Patient was hospitalized. Patient died on 07/01/2006.Vidaza Side Effects Report #5128618-1
Vidaza side effect was reported by a Physician from UNITED STATES on Sept 26, 2006. Male patient, 51 years of age, weighting 244.9 lb, was diagnosed with metastatic malignant melanoma and was treated with Vidaza. After drug was administered, patient experienced the following side effects: arthropod sting, iritis, local swelling. Vidaza dosage: 75 MG/M2 (DAILY X 3 DAYS EVERY 2 WEEKS), SUBCUTANEOUS. During the same period patient was treated with INTERFERON, AMBIEN CR, FERROUS SULPHATE, PERCOCET, SYNTHROID.
Vidaza Side Effects Report #5144297-1
Consumer or non-health professional from UNITED STATES reported Vidaza side effect on Oct 18, 2006. Female patient, 71 years of age, weighting 150.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain upper, caecitis, vomiting. Vidaza dosage: unknown. Patient was hospitalized.
Vidaza Side Effects Report #5145543-0
Vidaza side effect was reported by a Physician from UNITED STATES on Oct 17, 2006. Female patient, 79 years of age, weighting 183.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, dilatation atrial, epistaxis, thrombocytopenia, ventricular extrasystoles, ventricular hypertrophy. Vidaza dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, SPIRIVA, ADVAIR DISKUS, FLONASE, ALLEGRA, ZOLOFT, FOLATE, METAMUCIL. Patient was hospitalized.
Vidaza Side Effects Report #5146393-1
Physician from UNITED STATES reported Vidaza side effect on Oct 19, 2006. Male patient, 75 years of age, weighting 182.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: amyotrophic lateral sclerosis
, bedridden, blood product transfusion dependent, gait disturbance, nerve injury, polyneuropathy. Vidaza dosage: unknown. During the same period patient was treated with SIMVASTATIN. Vidaza Side Effects Report #5154593-X
Vidaza side effect was reported by a Physician from ITALY on Oct 26, 2006. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cerebral ischaemia, coma hepatic, hepatic failure, hepatic necrosis, pneumonia
. Vidaza dosage: 60 MG/M2 (100 MG, DAILY X 8 DAYS, WITHOUT WEEKEND DOSING), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, TRETINOIN, DANAZOLE. Patient died.Vidaza Side Effects Report #5166006-2
Health Professional from UNITED STATES reported Vidaza side effect on Nov 16, 2006. Female patient, 47 years of age, weighting 115.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pancreatitis. Vidaza dosage: 56 MG/M2 (88 MG, DAILY), SUBCUTANEOUS. During the same period patient was treated with ZOLOFT, QUINAPRIL, PRAVASTATIN, NISOLDIPINE, LORATADINE. Patient was hospitalized.
Vidaza Side Effects Report #5166385-6
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2006. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: haemorrhage, pneumonia
, renal failure, sepsis . Vidaza dosage: unknown. Patient was hospitalized. Patient died on 02/01/2006.Vidaza Side Effects Report #5170131-X
Physician from UNITED STATES reported Vidaza side effect on Nov 16, 2006. Female patient, 47 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atelectasis, cardiac arrest
, carotid artery aneurysm, carotid artery atheroma, constipation , electrocardiogram qt corrected interval prolonged, febrile neutropenia, hypokalaemia, hypomagnesaemia. Vidaza dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with AMBISOME, NORFLOXACIN, ZOFRAN, REGLAN, BENADRYL, PROTONIX, TYLENOL. Patient was hospitalized. Vidaza Side Effects Report #5178223-6
Vidaza side effect was reported by a Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on Nov 24, 2006. Female patient, 68 years of age, weighting 72.75 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: ascites, bone marrow failure, nausea
, peritonitis, pneumonia . Vidaza dosage: 75 MG/M2 (DAILY X 7. Patient was hospitalized. Patient died on 11/18/2006.Vidaza Side Effects Report #5178225-X
Physician from PHILIPPINES reported Vidaza side effect on Nov 23, 2006. Male patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: disease progression. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. Patient died.
Vidaza Side Effects Report #5187668-X
Vidaza side effect was reported by a Physician from UNITED STATES on Nov 28, 2006. Male patient, 75 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bacterial infection
, bronchial obstruction, pancytopenia, pneumonia fungal, sputum culture positive. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with FORTAZ, FLEXERIL, AVODART, LOTEMAX, PROTONIX, ZOCOR, BENADRYL, TYLENOL. Patient was hospitalized. Patient died on 12/05/2006.Vidaza Side Effects Report #5189382-3
Health Professional from FRANCE reported Vidaza side effect on Dec 01, 2006. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bone marrow failure, bone marrow transplant
, bronchopulmonary aspergillosis, condition aggravated, febrile bone marrow aplasia, pancytopenia. Vidaza dosage: 75 MG/M2 (DAILY X 6 DAYS), SUBCUTANEOUS. During the same period patient was treated with DANATROL, ARANESP. Patient was hospitalized. Vidaza Side Effects Report #5191605-1
Vidaza side effect was reported by a Physician from ITALY on Dec 04, 2006. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cerebral ischaemia, coagulopathy, coma hepatic, condition aggravated, hepatic failure, hepatic necrosis, hepatotoxicity, international normalised ratio increased, neutrophil count decreased. Vidaza dosage: 60 MG/M2 (100 MG, DAILY X 8 DAYS, WITHOUT WEEKEND DOSING), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, DANAZOLE, TRETINOIN. Patient died on 10/24/2006.
Vidaza Side Effects Report #5193880-6
Physician from UNITED STATES reported Vidaza side effect on Dec 19, 2006. Male patient, 74 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: hypotension, hypoxia, interstitial lung disease, supraventricular tachycardia. Vidaza dosage: (85 MG, DAILY X 10 DAYS), SUBCUTANEOUS. During the same period patient was treated with TOPROL, FOLTX, ZOLOFT, CARDURA, ZYRTEC, ARANESP. Patient was hospitalized. Patient died on 10/23/2006.
Vidaza Side Effects Report #5195824-X
Vidaza side effect was reported by a Physician from UNITED STATES on Dec 14, 2006. Female patient, 69 years of age, weighting 158.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, bacteria stool identified, bacterial infection
, blood pressure decreased, catheter sepsis, condition aggravated, heart rate decreased, heart rate increased, nausea . Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with ZOLOFT, XANAX, ASCORBIC ACID, IRON, CYANOCOBALAMIN, SPIRIVA, ALBUTEROL. Patient was hospitalized. Patient died on 12/12/2006.Vidaza Side Effects Report #5380511-5
Physician from UNITED KINGDOM reported Vidaza side effect on June 21, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, nausea
, polychromasia, red blood cell spherocytes present. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS),INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR. Vidaza Side Effects Report #5385214-9
Vidaza side effect was reported by a Physician from UNITED KINGDOM on June 22, 2007. Male patient, 68 years of age, weighting 154.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abscess intestinal. Vidaza dosage: (75 MG/M2, SUBCUTANEOUS. During the same period patient was treated with CIPROFLOXACIN, NYSTATIN, ACYCLOVIR. Patient was hospitalized.
Vidaza Side Effects Report #5397276-3
Physician from GERMANY reported Vidaza side effect on July 09, 2007. Male patient, 55 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis of nausea and vomiting and was treated with Vidaza. After drug was administered, patient experienced the following side effects: aggression. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with ONDANSETRON. Patient was hospitalized.
Vidaza Side Effects Report #5398952-9
Vidaza side effect was reported by a Pharmacist from UNITED STATES on July 24, 2007. Female patient, 81 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pancytopenia. Vidaza dosage: unknown. During the same period patient was treated with TYLENOL, HEPARIN, AZTREONAM, CIPROFLOXACIN, ALBUTEROL, IPRATROPIUM BROMIDE, BACTRIM, VANCOMYCIN. Patient was hospitalized. Patient died on 04/04/2006.
Vidaza Side Effects Report #5402040-2
Physician from FRANCE reported Vidaza side effect on July 12, 2007. Male patient, 55 years of age, weighting 220.5 lb, was diagnosed with myelodysplastic syndrome, thrombosis prophylaxis, pyrexia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bacterial infection
, catheter related infection, culture urine positive, escherichia infection, international normalised ratio increased, pneumonia klebsiella, sepsis . Vidaza dosage: 120 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with PREVISCAN, AMOXICILLIN, ATENOLOL. Patient was hospitalized. Vidaza Side Effects Report #5413136-3
Vidaza side effect was reported by a Physician from UNITED STATES on July 26, 2007. Female patient, 78 years of age, weighting 140.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, thrombocytopenia, urinary tract infection
. Vidaza dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, ATENOLOL. Patient was hospitalized. Vidaza Side Effects Report #5422042-X
Physician from UNITED STATES reported Vidaza side effect on Aug 03, 2007. Female patient, 80 years of age, weighting 145.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, carotid arteriosclerosis, haemoglobin decreased, heart rate irregular, hypotension, iron overload, local swelling, loss of consciousness, pyrexia. Vidaza dosage: 75 MG/M2, INTRAVENOUS. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ENALAPRIL, METOPROLOL TARTRATE, ASPIRIN, DEFERASIROX. Patient was hospitalized.
Vidaza Side Effects Report #5422150-3
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Aug 03, 2007. Male patient, 55 years of age, weighting 149.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial flutter, chest x-ray abnormal, diarrhoea, disease recurrence, hypertension, hypotension, pyrexia, tachycardia. Vidaza dosage: 135 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE, CIPROFLOXACIN, ACYCLOVIR, ALLOPURINOL, PENICILLIN V, LANSOPRAZOLE. Patient was hospitalized.
Vidaza Side Effects Report #5443288-0
Physician from GERMANY reported Vidaza side effect on Aug 16, 2007. Male patient, 59 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, aplasia, atrial fibrillation
, catheter site haemorrhage, convulsion, febrile neutropenia, haemoptysis, left ventricular failure. Vidaza dosage: (100 MG/M2), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, NEUPOGEN. Patient was hospitalized. Patient died on 07/15/2007.Vidaza Side Effects Report #5449798-4
Vidaza side effect was reported by a Physician from ITALY on Aug 29, 2007. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, aspergillosis, blood pressure increased, cytomegalovirus infection
, epstein-barr virus infection, heart rate increased, pneumocystis jiroveci pneumonia, urinary retention. Vidaza dosage: (140 MG, DAILY X 7). During the same period patient was treated with VALPROIC ACID. Patient was hospitalized. Patient died on 08/24/2007.Vidaza Side Effects Report #5455009-6
Physician from FRANCE reported Vidaza side effect on Aug 28, 2007. Female patient, 76 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: encephalopathy. Vidaza dosage: 119.3 MG (119.3 MG, DAILY X 7 DAYS), INTRAVENOUS. During the same period patient was treated with VALPROIC ACID, PROPRANOLOL, LEVOTHYROXINE, DESLORATADINE, GINKGO BILOBA. Patient was hospitalized and became disabled.
Vidaza Side Effects Report #5467580-9
Vidaza side effect was reported by a Physician from UNITED STATES on Sept 07, 2007. Male patient, 43 years of age, weighting 242.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain
, acute febrile neutrophilic dermatosis, post procedural haematoma, renal failure, respiratory failure, sepsis , vocal cord disorder. Vidaza dosage: (75 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with VORINOSTAT. Patient was hospitalized. Vidaza Side Effects Report #5472682-7
Physician from ITALY reported Vidaza side effect on Sept 11, 2007. Female patient, 61 years of age, weighting 143.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood culture positive, candidiasis, depressed level of consciousness, neutropenia, pneumonia fungal, septic shock. Vidaza dosage: (125 MG, DAILY X DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, EUTIROX, VALPRESSION. Patient died on 09/02/2007.
Vidaza Side Effects Report #5482167-X
Vidaza side effect was reported by a Physician from FRANCE on Sept 21, 2007. Female patient, 76 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acinetobacter bacteraemia, encephalopathy, vessel puncture site haematoma. Vidaza dosage: 119 MG, DAILY X 7 DAYS, INTRAVENOUS. During the same period patient was treated with VALPROIC ACID, PROPRANOLOL, LEVOTHYROXINE, DESLORATADINE, GINKGO BILOBA, TRETINOIN, ONDANSETRON, DOMPERIDONE. Patient was hospitalized and became disabled.
Vidaza Side Effects Report #5485942-0
Physician from FRANCE reported Vidaza side effect on Oct 08, 2007. Female patient, 76 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acinetobacter bacteraemia, encephalopathy, malignant neoplasm progression, vessel puncture site haematoma. Vidaza dosage: (119 MG, DAILY X 7 DAYS), INTRAVENOUS. During the same period patient was treated with VALPROIC ACID, PROPRANOLOL, LEVOTHYROXINE, DESLORATADINE, GINKGO BILOBA, TRETINOIN, ONDANSETRON, DOMPERIDONE. Patient was hospitalized and became disabled.
Vidaza Side Effects Report #5486003-7
Vidaza side effect was reported by a Physician from ITALY on Sept 28, 2007. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, aspergillosis, blood pressure increased, cytomegalovirus infection
, epstein-barr virus infection, haemoglobin decreased, platelet count decreased, pneumocystis jiroveci pneumonia, urinary retention. Vidaza dosage: (140 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, BACTRIM, PREDNISONE, RABEPRAZOLE, FOSFAMICINA, TROMETAMOLO, CARVEDILOLO. Patient was hospitalized. Patient died on 08/24/2007.Showing 1-50 of 226 Next >
83%